Posts

This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!
Business, News, Stock ReportsThis week in psychedelic stock news, there are big patent developments for Compass, MindMed and Numinus.

Psychedelic Business Spotlight – June 17
Business, News, Stock ReportsThis week in psychedelic business news: ARK Invest advances deep dive into psychedelic stocks; Cybin moves closer to clinical trials, and more!

Psychedelic Business Spotlight – June 10
Business, Stock ReportsThis week in psychedelic business news: Cybin acquires a Phase 1 DMT trial from Entheon; Numinus completed the acquisition of Novamind, MindMed's stock is removed from an index; and...

5 Next-Generation Psychedelics Entering Clinical Trials This Year
Editorial, ResearchModernized psychedelic medicine is coming, whether you like it or not, so here are five of the most exciting next-generation psychedelics on the horizon.

Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
Business, EditorialPsychedelic investors are about to see pivotal data presented on flagship programs by the titans of the psychedelics industry.

Elon Musk Excites Psychedelic Industry CEOs with This Tweet
Business, NewsThis is one of the billionaire's most explicit acknowledgments of the power of psychedelics for mental health applications.

My Favorite Psychedelic Stocks: Part 1
Business, EditorialOur resident Psychedelic Investor details five companies he thinks are in strong position to win the psychedelic medicine race.

Psychedelic Business Spotlight – February 18
Business, Stock ReportsThis week in psychedelic business news: Nova Mentis makes progress on autism; atai donates to MAPS; Cathie Wood eyes more psychedelic stocks.

Cybin Partners with The Chopra Foundation to Bring Awareness to the Benefits of Psychedelic-Based Therapies
Business "The need for new and more effective treatments across the mental health spectrum is more urgent today than ever," says Dr. Deepak Chopra.

Psychedelic Business Spotlight – February 11
Business, Stock ReportsThis week in psychedelic business news: Cybin scores another patent; another huge psychedelics conference heads to Miami; Core One Labs widens pipeline with another drug.